{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:56:16Z","timestamp":1783698976743,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04318-1","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:10:45Z","timestamp":1753711845000},"page":"1091-1108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The synergistic effect of resveratrol and curcumin on oncogenic lncRNA MAPT-IT1 and ferroptosis-related genes in breast cancer"],"prefix":"10.1007","volume":"399","author":[{"given":"Fahad","family":"Alsaikhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"4318_CR1","doi-asserted-by":"crossref","unstructured":"Arena A et al (2021) New insights into curcumin- and resveratrol-mediated anti-cancer effects. Pharm 14","DOI":"10.3390\/ph14111068"},{"key":"4318_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15\u201323","journal-title":"Breast"},{"key":"4318_CR3","doi-asserted-by":"crossref","first-page":"154507","DOI":"10.1016\/j.prp.2023.154507","volume":"246","author":"R Asemi","year":"2023","unstructured":"Asemi R et al (2023) Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: a comprehensive review. Pathology-Research and Practice 246:154507","journal-title":"Pathology-Research and Practice"},{"issue":"2","key":"4318_CR4","first-page":"116","volume":"20","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M et al (2020) Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury. Curr Mol Med 20(2):116\u2013133","journal-title":"Curr Mol Med"},{"key":"4318_CR5","doi-asserted-by":"crossref","unstructured":"Bhushan A, Gonsalves A, Menon JU (2021) Current state of breast cancer diagnosis, treatment, and theranostics. Pharm 13(5)","DOI":"10.3390\/pharmaceutics13050723"},{"key":"4318_CR6","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/1538-7445.AM2013-2576","volume":"73","author":"A Chatterjee","year":"2013","unstructured":"Chatterjee A et al (2013) Abstract 2576: Novel resveratrol analog ARSHA shows higher potency for inhibiting the growth of triple negative breast cancer cells. Can Res 73:2576\u20132576","journal-title":"Can Res"},{"key":"4318_CR7","doi-asserted-by":"crossref","unstructured":"Cheng T et al (2022) Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer. Free Radic Biol Med","DOI":"10.1016\/j.freeradbiomed.2022.01.010"},{"issue":"27","key":"4318_CR8","doi-asserted-by":"crossref","first-page":"41203","DOI":"10.18632\/oncotarget.9754","volume":"7","author":"JR Costa","year":"2016","unstructured":"Costa JR et al (2016) Autophagy gene expression profiling identifies a defective microtubule-associated protein light chain 3A mutant in cancer. Oncotarget 7(27):41203\u201341216","journal-title":"Oncotarget"},{"issue":"5","key":"4318_CR9","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3892\/or.2013.2310","volume":"29","author":"Q Du","year":"2013","unstructured":"Du Q et al (2013) Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol Rep 29(5):1851\u20131858","journal-title":"Oncol Rep"},{"issue":"10","key":"4318_CR10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.293.10.1245","volume":"293","author":"JG Elmore","year":"2005","unstructured":"Elmore JG et al (2005) Screening for breast cancer. JAMA 293(10):1245\u20131256","journal-title":"JAMA"},{"key":"4318_CR11","doi-asserted-by":"crossref","unstructured":"Focaccetti C et al (2023) The combination of bioavailable concentrations of curcumin and resveratrol shapes immune responses while retaining the ability to reduce cancer cell survival. Int J Mol Sci","DOI":"10.3390\/ijms25010232"},{"issue":"10","key":"4318_CR12","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/nu11102376","volume":"11","author":"A Giordano","year":"2019","unstructured":"Giordano A, Tommonaro G (2019) Curcumin and cancer. Nutrients 11(10):2376","journal-title":"Nutrients"},{"issue":"15","key":"4318_CR13","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.3390\/ijms25158077","volume":"25","author":"M Gonz\u00e1lez-Woge","year":"2024","unstructured":"Gonz\u00e1lez-Woge M et al (2024) The expression profiles of lncRNAs are associated with neoadjuvant chemotherapy resistance in locally advanced, luminal B-type breast cancer. Int J Mol Sci 25(15):8077","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4318_CR14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1109\/TNB.2023.3242912","volume":"22","author":"ZR Harandi","year":"2023","unstructured":"Harandi ZR, Heidari R, Reiisi S (2023) Co-delivery of silymarin and metformin dual-loaded in mesoporous silica nanoparticles synergistically sensitizes breast cancer cell line to mitoxantrone chemotherapy. IEEE Trans Nanobiosci 22(4):872\u2013880","journal-title":"IEEE Trans Nanobiosci"},{"key":"4318_CR15","doi-asserted-by":"crossref","unstructured":"Hoque N et al (2024) Comprehensive review of breast cancer risk factors, diagnosis, screening, and treatment methods. J Appl Pharm Res","DOI":"10.69857\/joapr.v12i5.606"},{"issue":"1","key":"4318_CR16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cbin.11942","volume":"47","author":"SS Hosseini","year":"2023","unstructured":"Hosseini SS et al (2023) Study of quercetin and fisetin synergistic effect on breast cancer and potentially involved signaling pathways. Cell Biol Int 47(1):98\u2013109","journal-title":"Cell Biol Int"},{"issue":"10","key":"4318_CR17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2174\/1567201818666210518170139","volume":"18","author":"SK Jain","year":"2021","unstructured":"Jain SK et al (2021) Novel self-micro emulsifying drug delivery system for safe intramuscular delivery with improved pharmacodynamics and pharmacokinetics. Curr Drug Deliv 18(10):1533\u20131549","journal-title":"Curr Drug Deliv"},{"issue":"9","key":"4318_CR18","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1007\/s11033-023-08664-2","volume":"50","author":"M JalalpourChoupanan","year":"2023","unstructured":"JalalpourChoupanan M, Shahbazi S, Reiisi S (2023) Naringenin in combination with quercetin\/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines. Mol Biol Rep 50(9):7489\u20137500","journal-title":"Mol Biol Rep"},{"issue":"7","key":"4318_CR19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/15459683211011232","volume":"35","author":"W Jin","year":"2021","unstructured":"Jin W, Botchway BOA, Liu X (2021) Curcumin can activate the Nrf2\/HO-1 signaling pathway and scavenge free radicals in spinal cord injury treatment. Neurorehabil Neural Repair 35(7):576\u2013584","journal-title":"Neurorehabil Neural Repair"},{"key":"4318_CR20","doi-asserted-by":"crossref","first-page":"9605439","DOI":"10.1155\/2022\/9605439","volume":"2022","author":"D Kashyap","year":"2022","unstructured":"Kashyap D et al (2022) Global increase in breast cancer incidence: risk factors and preventive measures. Biomed Res Int 2022:9605439","journal-title":"Biomed Res Int"},{"issue":"1","key":"4318_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.gco.0000192996.20040.24","volume":"18","author":"AE Kayl","year":"2006","unstructured":"Kayl AE, Meyers CA (2006) Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol 18(1):24\u201328","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"4318_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","volume":"2","author":"TJ Key","year":"2001","unstructured":"Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2(3):133\u2013140","journal-title":"Lancet Oncol"},{"issue":"12","key":"4318_CR23","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijms18122589","volume":"18","author":"J-H Ko","year":"2017","unstructured":"Ko J-H et al (2017) The role of resveratrol in cancer therapy. Int J Mol Sci 18(12):2589","journal-title":"Int J Mol Sci"},{"key":"4318_CR24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-013-2727-3","volume":"142","author":"I Kuchuk","year":"2013","unstructured":"Kuchuk I et al (2013) Preference weights for chemotherapy side effects from the perspective of women with breast cancer. Breast Cancer Res Treat 142:101\u2013107","journal-title":"Breast Cancer Res Treat"},{"key":"4318_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2741\/s427","volume":"7","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sharma S, Watabe K (2015) Roles of lncRNA in breast cancer. Front Biosci (Schol Ed) 7:94","journal-title":"Front Biosci (Schol Ed)"},{"issue":"1","key":"4318_CR26","first-page":"20","volume":"42","author":"Y Liu","year":"2019","unstructured":"Liu Y et al (2019) The targeting of non-coding RNAs by curcumin: facts and hopes for cancer therapy. Oncol Rep 42(1):20\u201334","journal-title":"Oncol Rep"},{"key":"4318_CR27","doi-asserted-by":"crossref","unstructured":"\u0141ukasiewicz S et al (2021) Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel)","DOI":"10.3390\/cancers13174287"},{"issue":"12","key":"4318_CR28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","volume":"7","author":"R Mathew","year":"2007","unstructured":"Mathew R, Karantza-Wadsworth V, White E (2007) Role of autophagy in cancer. Nat Rev Cancer 7(12):961\u2013967","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"4318_CR29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.4161\/auto.7.12.17802","volume":"7","author":"M Mauthe","year":"2011","unstructured":"Mauthe M et al (2011) Resveratrol-mediated autophagy requires WIPI-1-regulated LC3 lipidation in the absence of induced phagophore formation. Autophagy 7(12):1448\u20131461","journal-title":"Autophagy"},{"key":"4318_CR30","doi-asserted-by":"crossref","unstructured":"Naeem A et al (2022) Natural products as anticancer agents: current status and future perspectives. Mol","DOI":"10.3390\/molecules27238367"},{"key":"4318_CR31","doi-asserted-by":"crossref","unstructured":"Ochoa-Sanchez A et al (2024) Evaluation of the synergistic effects of curcumin-resveratrol co-loaded biogenic silica on colorectal cancer cells. Front Pharm","DOI":"10.3389\/fphar.2024.1341773"},{"issue":"9","key":"4318_CR32","doi-asserted-by":"crossref","first-page":"e7109","DOI":"10.1371\/journal.pone.0007109","volume":"4","author":"D Paccagnini","year":"2009","unstructured":"Paccagnini D et al (2009) Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS ONE 4(9):e7109","journal-title":"PLoS ONE"},{"issue":"1","key":"4318_CR33","doi-asserted-by":"crossref","first-page":"e23637","DOI":"10.1002\/bip.23637","volume":"116","author":"P Pandey","year":"2025","unstructured":"Pandey P et al (2025) An updated review summarizing the anticancer potential of poly(lactic-co-glycolic acid) (PLGA) based curcumin, epigallocatechin gallate, and resveratrol nanocarriers. Biopolymers 116(1):e23637","journal-title":"Biopolymers"},{"issue":"1","key":"4318_CR34","doi-asserted-by":"crossref","first-page":"21772","DOI":"10.1038\/srep21772","volume":"6","author":"D Park","year":"2016","unstructured":"Park D et al (2016) Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci Rep 6(1):21772","journal-title":"Sci Rep"},{"key":"4318_CR35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.semcancer.2020.10.010","volume":"73","author":"S Patra","year":"2021","unstructured":"Patra S et al (2021) Chemotherapeutic efficacy of curcumin and resveratrol against cancer: chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics. Semin Cancer Biol 73:310\u2013320","journal-title":"Semin Cancer Biol"},{"key":"4318_CR36","doi-asserted-by":"crossref","unstructured":"Pavan A et al (2016) Unraveling the anticancer effect of curcumin and resveratrol. Nutr","DOI":"10.3390\/nu8110628"},{"key":"4318_CR37","doi-asserted-by":"crossref","first-page":"1263988","DOI":"10.3389\/fimmu.2023.1263988","volume":"14","author":"J Qin","year":"2023","unstructured":"Qin J et al (2023) Identification of autophagy-related genes in osteoarthritis articular cartilage and their roles in immune infiltration. Front Immunol 14:1263988","journal-title":"Front Immunol"},{"issue":"1","key":"4318_CR38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12964-021-00706-1","volume":"19","author":"M Sadria","year":"2021","unstructured":"Sadria M, Layton AT (2021) Interactions among mTORC, AMPK and SIRT: a computational model for cell energy balance and metabolism. Cell Commun Signal 19(1):57","journal-title":"Cell Commun Signal"},{"key":"4318_CR39","doi-asserted-by":"crossref","unstructured":"Satherley L, Davies EL (2023) Breast cancer. Med","DOI":"10.1016\/j.mpmed.2022.10.008"},{"key":"4318_CR40","first-page":"113","volume":"31","author":"B Schmidt","year":"2020","unstructured":"Schmidt B et al (2020) Synergistic effect of curcumin, piperine and resveratrol in MCF-7 and MDA MB-231 breast cancer cells. Biomed Res-Tokyo 31:113\u2013117","journal-title":"Biomed Res-Tokyo"},{"issue":"16_suppl","key":"4318_CR41","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.1200\/JCO.2023.41.16_suppl.10528","volume":"41","author":"ET Sedeta","year":"2023","unstructured":"Sedeta ET, Jobre B, Avezbakiyev B (2023) Breast cancer: Global patterns of incidence, mortality, and trends. J Clin Oncol 41(16_suppl):10528\u201310528","journal-title":"J Clin Oncol"},{"issue":"1","key":"4318_CR42","first-page":"9750785","volume":"2016","author":"A Shindikar","year":"2016","unstructured":"Shindikar A et al (2016) Curcumin and resveratrol as promising natural remedies with nanomedicine approach for the effective treatment of triple negative breast cancer. J Oncol 2016(1):9750785","journal-title":"J Oncol"},{"issue":"5","key":"4318_CR43","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/med.21565","volume":"39","author":"AP Singh","year":"2019","unstructured":"Singh AP et al (2019) Health benefits of resveratrol: evidence from clinical studies. Med Res Rev 39(5):1851\u20131891","journal-title":"Med Res Rev"},{"issue":"12","key":"4318_CR44","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1080\/15548627.2020.1719746","volume":"16","author":"JA Stefely","year":"2020","unstructured":"Stefely JA et al (2020) Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagy. Autophagy 16(12):2219\u20132237","journal-title":"Autophagy"},{"issue":"45","key":"4318_CR45","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.3748\/wjg.v16.i45.5727","volume":"16","author":"LC Stewart","year":"2010","unstructured":"Stewart LC et al (2010) SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status. World J Gastroenterol 16(45):5727\u20135731","journal-title":"World J Gastroenterol"},{"issue":"11","key":"4318_CR46","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"Y-S Sun","year":"2017","unstructured":"Sun Y-S et al (2017) Risk factors and preventions of breast cancer. Int J Biol Sci 13(11):1387","journal-title":"Int J Biol Sci"},{"key":"4318_CR47","first-page":"S149","volume":"24","author":"JJ Tao","year":"2015","unstructured":"Tao JJ, Visvanathan K, Wolff AC (2015) Long term side effects of adjuvant chemotherapy in patients with early breast cancer. The Breast 24:S149\u2013S153","journal-title":"The Breast"},{"issue":"3","key":"4318_CR48","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288\u2013300","journal-title":"JAMA"},{"key":"4318_CR49","doi-asserted-by":"crossref","first-page":"660712","DOI":"10.3389\/fonc.2021.660712","volume":"11","author":"H Wang","year":"2021","unstructured":"Wang H et al (2021) Curcumin regulates cancer progression: focus on ncRNAs and molecular signaling pathways. Front Oncol 11:660712","journal-title":"Front Oncol"},{"issue":"4","key":"4318_CR50","first-page":"3737","volume":"18","author":"Y Wu","year":"2018","unstructured":"Wu Y et al (2018) Bioinformatics analysis to screen for critical genes between survived and non-survived patients with sepsis. Mol Med Rep 18(4):3737\u20133743","journal-title":"Mol Med Rep"},{"key":"4318_CR51","doi-asserted-by":"crossref","unstructured":"Wu L et al (2023) Effects of curcumin on oxidative stress and ferroptosis in acute ammonia stress-induced liver injury in Gibel Carp (Carassius gibelio). Int J Mol Sci 24(7)","DOI":"10.3390\/ijms24076441"},{"issue":"16","key":"4318_CR52","doi-asserted-by":"crossref","first-page":"e42146","DOI":"10.1097\/MD.0000000000042146","volume":"104","author":"X Yang","year":"2025","unstructured":"Yang X, Wang Y (2025) Prognosis stratification of patients with breast cancer based on disulfidptosis and ferroptosis. Med 104(16):e42146","journal-title":"Med"},{"issue":"11","key":"4318_CR53","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","volume":"1839","author":"G Yang","year":"2014","unstructured":"Yang G, Lu X, Yuan L (2014) LncRNA: a link between RNA and cancer. Biochimica et Biophysica Acta (BBA)-Gene Regul Mech 1839(11):1097\u20131109","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regul Mech"},{"issue":"1","key":"4318_CR54","doi-asserted-by":"crossref","first-page":"2390764","DOI":"10.1155\/2022\/2390764","volume":"2022","author":"Z-Y Yao","year":"2022","unstructured":"Yao Z-Y et al (2022a) Development and validation of ferroptosis-related lncRNAs as prognosis and diagnosis biomarkers for breast cancer. Biomed Res Int 2022(1):2390764","journal-title":"Biomed Res Int"},{"key":"4318_CR55","doi-asserted-by":"crossref","first-page":"2390764","DOI":"10.1155\/2022\/2390764","volume":"2022","author":"ZY Yao","year":"2022","unstructured":"Yao ZY et al (2022b) Development and validation of ferroptosis-related lncRNAs as prognosis and diagnosis biomarkers for breast cancer. Biomed Res Int 2022:2390764","journal-title":"Biomed Res Int"},{"issue":"2","key":"4318_CR56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L et al (2022) Ferroptosis in cancer and cancer immunotherapy. Cancer Commun 42(2):88\u2013116","journal-title":"Cancer Commun"},{"key":"4318_CR57","doi-asserted-by":"crossref","unstructured":"\u017divanovi\u0107 N et al (2024) Beyond mortality: exploring the influence of plant phenolics on modulating ferroptosis\u2014a systematic review. Antioxid","DOI":"10.3390\/antiox13030334"}],"updated-by":[{"DOI":"10.1007\/s00210-025-04816-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000}}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04318-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:06:14Z","timestamp":1771538774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04318-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4318"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04318-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00210-025-04816-2","URL":"https:\/\/doi.org\/10.1007\/s00210-025-04816-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Prince Sattam bin Abdulaziz University (project number: PSAU\/2023\/R\/1444).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, consent to participate, and consent for publication"}},{"value":"During the preparation of this work, the authors used ChatGPT by OpenAI to improve paper readability. After using this tool\/service, the authors reviewed and edited the content as needed and took full responsibility for the publication\u2019s content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}